Perioperative Trials Add to Growing Immunotherapy Landscape in Early-Stage NSCLC

Emerging data continue to shape perioperative therapy decisions for patients with early-stage non–small cell lung cancer.

Related Keywords

Copenhagen ,Køavn ,Denmark ,California ,United States ,Stanford University ,Pamela Miel ,Heather Wakelee ,Girardn Neoadjuvant ,Stanford Cancer Institute ,European Lung Cancer Congress ,Oncology Institute Of Hope Innovation ,Scientific Interchange ,Stanford University School ,International Association ,Lung Cancer ,Oncology Institute ,Onclive Scientific Interchange ,Lung Cancer Congress ,Non Small Cell Lung Cancer ,Nsclc ,D ,